Quarterly report [Sections 13 or 15(d)]

Accrued and Other Current Liabilities

v3.26.3
Accrued and Other Current Liabilities
9 Months Ended
Sep. 30, 2026
Payables and Accruals [Abstract]  
Accrued and Other Current Liabilities

4. Accrued and Other Current Liabilities

Accrued and other current liabilities consist of the following:

 

 

 

September 30,
2026

 

 

December 31,
2025

 

Compensation expense

 

$

7,946

 

 

$

9,716

 

Manufacturing and other research and development services

 

 

6,909

 

 

 

3,774

 

Clinical trial research and development services

 

 

5,268

 

 

 

5,335

 

General and administrative services

 

 

160

 

 

 

393

 

Other

 

 

70

 

 

 

80

 

 

 

$

20,353

 

 

$

19,298